Author:
Wei Dengshuai,Fan Haoru,Zheng Kun,Qin Xuemei,Yang Leifu,Yang Yajuan,Duan Ye,Zhang Qiang,Zeng Chengchu,Hu Liming
Funder
Beijing Key Laboratory of Environmental & Viral Oncology
Beijing Scitech-MQ Pharmaceuticals Limited STTG002 project funds and development funds
Beijing Key Laboratory for Green Catalysis and Separation
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference22 articles.
1. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets;Feitelsona;Semin. Cancer Biol.,2015
2. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth;Yakes;Mol. Cancer Ther.,2011
3. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases;Qian;Cancer Res.,2009
4. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs;Zhang;Eur. J. Med. Chem.,2016
5. Met, metastasis, motility and more;Birchmeier;Nat. Rev. Mol. Cell Biol.,2003
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献